Alvogen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?
ALVOGEN has fifty-seven approved drugs.
There are two tentative approvals on ALVOGEN drugs.
Summary for Alvogen
US Patents: | 0 |
Tradenames: | 47 |
Ingredients: | 45 |
NDAs: | 57 |
Patent Litigation for Alvogen: | See patent lawsuits for Alvogen |
PTAB Cases with Alvogen as petitioner: | See PTAB cases with Alvogen as petitioner |
Drugs and US Patents for Alvogen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alvogen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210818-004 | Nov 30, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alvogen | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 207490-002 | May 17, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alvogen | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 202116-003 | Dec 30, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alvogen | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 210818-002 | Nov 30, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Alvogen | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 204403-003 | Aug 31, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alvogen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-004 | Aug 23, 1988 | 3,800,481 | ⤷ Try a Trial |
Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-003 | Aug 1, 1984 | 4,012,444 | ⤷ Try a Trial |
Alvogen | LIDEX | fluocinonide | CREAM;TOPICAL | 016908-002 | Approved Prior to Jan 1, 1982 | 3,592,930 | ⤷ Try a Trial |
Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-001 | May 24, 1985 | 4,012,444 | ⤷ Try a Trial |
Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-002 | Oct 31, 1985 | 4,642,384 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.